Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease

作者: Norishi Ueda , Kazuya Takasawa

DOI: 10.3390/NU10091173

关键词: Direct reduced ironInflammationGastroenterologyIron-deficiency anemiaInternal medicineKidney diseaseFerroportinMedicineFerritinHepcidinC-reactive protein

摘要: Iron deficiency anemia (IDA) is a major problem in chronic kidney disease (CKD), causing increased mortality. Ferritin stores iron, representing iron status. Hepcidin binds to ferroportin, thereby inhibiting absorption/efflux. Inflammation CKD increases ferritin and hepcidin independent of status, which reduce availability. While intravenous therapy (IIT) superior oral (OIT) patients with inflammation, OIT as effective IIT those without. reduces predictive values for status responsiveness therapy. Upper limit predict overload higher inflammation than However, magnetic resonance imaging studies show lower cutoff levels serum dialysis apparent upper proposed by international guidelines. Compared optimal IDA are without, requiring reduced dose leading decreased The management should differ between without include minimization inflammation. Further needed determine the impact on ferritin, therapeutic strategy CKD.

参考文章(215)
K. Hamulyak, M.M.H. Hermans, J.P. Kooman, F.M. van der Sande, M.P. van Dieijen-Visser, K.M.L. Leunissen, C.M. Hackeng, C.M. Beerenhout, P.H. van der Kuy, H. van der Dussen, The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients Journal of Nephrology. ,vol. 17, pp. 107- 111 ,(2004)
Tian-Gu Hsiau, Po-Yaur Hsu, Chih-Wei Yang, Chun-Liang Lin, Ten-Hui Sun, Lan-Mei Huang, Chu-Chun Chien, Chun-Chen Yu, Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study. Journal of Nephrology. ,vol. 17, pp. 693- 700 ,(2004)
B Kalender, A Yilmaz, M Ersöz, A Kalkan, B Mutlu, The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients. International Journal of Clinical Practice. ,vol. 56, pp. 505- 508 ,(2002)
Jolanta Małyszko, Ewa Koc‑Żórawska, Nomy Levin‑Iaina, Jacek Małyszko, Piotr Koźmiński, Grażyna Kobus, Michał Myśliwiec, New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis. Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine. ,vol. 122, pp. 537- 542 ,(2012) , 10.20452/PAMW.1458
Ewelina Łukaszyk, Mateusz Łukaszyk, Ewa Koc-Żórawska, Jolanta Tobolczyk, Anna Bodzenta-Łukaszyk, Jolanta Małyszko, Iron Status and Inflammation in Early Stages of Chronic Kidney Disease Kidney & Blood Pressure Research. ,vol. 40, pp. 366- 373 ,(2015) , 10.1159/000368512
Kao-Chang Lin, Meng-Yi Tsai, Chun-Ling Chi, Lai-King Yu, Li-Hsueh Huang, Chien-An Chen, Serum ferritin is associated with arterial stiffness in hemodialysis patients: results of a 3-year follow-up study International Urology and Nephrology. ,vol. 47, pp. 1847- 1853 ,(2015) , 10.1007/S11255-015-1090-1
Moataz Fatthy Mohammed, Dawlat Belal, Seham Bakry, Mohamed A. Marie, Laila Rashed, Reham Emad Eldin, Samah Abd El-Hamid, A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus. Journal of Clinical Laboratory Analysis. ,vol. 28, pp. 306- 309 ,(2014) , 10.1002/JCLA.21685
Soichiro Iimori, Shotaro Naito, Yumi Noda, Hidenori Nishida, Hiromi Kihira, Naofumi Yui, Tomokazu Okado, Sei Sasaki, Shinichi Uchida, Tatemitsu Rai, Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study Nephrology. ,vol. 20, pp. 601- 608 ,(2015) , 10.1111/NEP.12493
Ajay Gupta, Vivian Lin, Carrie Guss, Raymond Pratt, T. Alp Ikizler, Anatole Besarab, Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients Kidney International. ,vol. 88, pp. 1187- 1194 ,(2015) , 10.1038/KI.2015.203